Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Topical testosterone for breast cancer patients with vaginal atrophy related to aromatase inhibitors: a phase I/II study.

Witherby S, Johnson J, Demers L, Mount S, Littenberg B, Maclean CD, Wood M, Muss H.

Oncologist. 2011;16(4):424-31. doi: 10.1634/theoncologist.2010-0435. Epub 2011 Mar 8.

2.

Vaginal estrogen therapy in postmenopausal breast cancer patients treated with aromatase inhibitors.

Moegele M, Buchholz S, Seitz S, Ortmann O.

Arch Gynecol Obstet. 2012 May;285(5):1397-402. doi: 10.1007/s00404-011-2181-6. Epub 2012 Jan 3. Review.

PMID:
22212649
3.

Local oestrogen for vaginal atrophy in postmenopausal women.

Suckling J, Lethaby A, Kennedy R.

Cochrane Database Syst Rev. 2003;(4):CD001500. Review. Update in: Cochrane Database Syst Rev. 2006;(4):CD001500.

PMID:
14583935
4.

Local oestrogen for vaginal atrophy in postmenopausal women.

Suckling J, Lethaby A, Kennedy R.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD001500. Review. Update in: Cochrane Database Syst Rev. 2016;8:CD001500.

PMID:
17054136
5.

Management of vulvovaginal atrophy-related sexual dysfunction in postmenopausal women: an up-to-date review.

Tan O, Bradshaw K, Carr BR.

Menopause. 2012 Jan;19(1):109-17. doi: 10.1097/gme.0b013e31821f92df. Review.

PMID:
22011753
6.

Vaginal estrogens for the treatment of dyspareunia.

Krychman ML.

J Sex Med. 2011 Mar;8(3):666-74. doi: 10.1111/j.1743-6109.2010.02114.x. Epub 2010 Nov 22. Review.

PMID:
21091878
7.

Vaginal DHEA to treat menopause related atrophy: a review of the evidence.

Panjari M, Davis SR.

Maturitas. 2011 Sep;70(1):22-5. doi: 10.1016/j.maturitas.2011.06.005. Epub 2011 Jul 5. Review.

PMID:
21733647
8.

Treatment of postmenopausal vaginal atrophy with 10-μg estradiol vaginal tablets.

Panay N, Maamari R.

Menopause Int. 2012 Mar;18(1):15-9. doi: 10.1258/mi.2012.011120. Review.

PMID:
22393176
9.

Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women.

Gibson LJ, Dawson C, Lawrence DH, Bliss JM.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD003370. Review. Update in: Cochrane Database Syst Rev. 2009;(4):CD003370.

PMID:
17253488
10.

Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview.

Al-Baghdadi O, Ewies AA.

Climacteric. 2009 Apr;12(2):91-105. doi: 10.1080/13697130802585576. Review.

PMID:
19117185
11.

Ultra-low-dose vaginal estrogen tablets for the treatment of postmenopausal vaginal atrophy.

Simon JA, Maamari RV.

Climacteric. 2013 Aug;16 Suppl 1:37-43. doi: 10.3109/13697137.2013.807606. Review.

PMID:
23848490
12.

Aromatase inhibitor-associated arthralgia syndrome.

Burstein HJ.

Breast. 2007 Jun;16(3):223-34. Epub 2007 Mar 21. Review.

PMID:
17368903
13.

Vaginal administration of estradiol: effects of dose, preparation and timing on plasma estradiol levels.

Santen RJ.

Climacteric. 2015 Apr;18(2):121-34. doi: 10.3109/13697137.2014.947254. Epub 2014 Oct 18. Review.

PMID:
25327484
14.

The role of aromatase inhibitors in early breast cancer.

Chung CT, Carlson RW.

Curr Treat Options Oncol. 2003 Apr;4(2):133-40. Review.

PMID:
12594939
15.

Non-hormonal topical treatment of vulvovaginal atrophy: an up-to-date overview.

Sinha A, Ewies AA.

Climacteric. 2013 Jun;16(3):305-12. doi: 10.3109/13697137.2012.756466. Epub 2013 Jan 8. Review.

PMID:
23215675
16.

Vaginal estrogen preparations: a review of safety and efficacy for vaginal atrophy.

Crandall C.

J Womens Health (Larchmt). 2002 Dec;11(10):857-77. Review.

PMID:
12626086
17.

Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women.

Gibson L, Lawrence D, Dawson C, Bliss J.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD003370. doi: 10.1002/14651858.CD003370.pub3. Review.

PMID:
19821307
18.

Should urogenital atrophy in breast cancer survivors be treated with topical estrogens?

Trinkaus M, Chin S, Wolfman W, Simmons C, Clemons M.

Oncologist. 2008 Mar;13(3):222-31. doi: 10.1634/theoncologist.2007-0234. Review.

19.

Effectively nursing patients receiving aromatase inhibitor therapy.

Wengström Y.

Breast. 2008 Jun;17(3):227-38. Epub 2008 Feb 20. Review.

PMID:
18077168
20.

Management of urogenital atrophy in breast cancer patients: a systematic review of available evidence from randomized trials.

Mazzarello S, Hutton B, Ibrahim MFK, Jacobs C, Shorr R, Smith S, Ng T, Clemons M.

Breast Cancer Res Treat. 2015 Jul;152(1):1-8. doi: 10.1007/s10549-015-3434-z. Epub 2015 May 24. Review.

PMID:
26003182

Supplemental Content

Support Center